Erleada 60 mg Alternative – Apaluda (Apalutamide) 60 mg Tablet | Beacon Pharmaceuticals
Apaluda 60 mg (Apalutamide) Tablet by Beacon Pharmaceuticals. Reference brand: Erleada. androgen receptor inhibitor; used in selected advanced prostate cancer. Prescription medicine. Brand comparison does not establish interchangeability.
Product Overview
Apaluda 60 mg Tablet is listed in the supplied Beacon Pharmaceuticals anti-cancer and hematology price list. The stated active ingredient is Apalutamide. Erleada is a reference brand for the generic ingredient. This is a product-identification comparison, not a claim of verified bioequivalence or interchangeability.
Apaluda vs Erleada – Reference Brand Comparison
Erleada is a recognized reference brand associated with Apalutamide. Apaluda is listed under Beacon Pharmaceuticals. Their excipients, marketing authorizations, formulation details and regulatory evidence may differ. A clinician or pharmacist must confirm whether substitution is appropriate.
Composition and Active Ingredient
Brand: Apaluda. Active ingredient: Apalutamide. Strength: 60 mg. Dosage form: Tablet. Therapeutic class: androgen receptor inhibitor. Listed manufacturer: Beacon Pharmaceuticals Ltd., Bangladesh. Packaging details should be confirmed on the manufacturer’s current pack.
Therapeutic Uses and Indications
Apalutamide is used in selected advanced prostate cancer. These are generic-level clinical contexts and do not independently confirm every indication for this particular branded presentation. Eligibility may depend on biomarkers, previous therapy and country-specific labeling.
Mechanism of Action – How Apalutamide Works
Apalutamide blocks androgen receptor signaling. This mechanism alone does not establish suitability or effectiveness for an individual patient.
Dosage and Administration
The 60 mg shown is the strength of this tablet, not a recommended daily dose. Dose, timing, food instructions and treatment duration must be determined by the treating specialist using the current authorized prescribing information. Do not change dose or substitute brands or strengths without medical approval.
Contraindications
Contraindications depend on Apalutamide, formulation and individual medical conditions. Review the current official prescribing information, particularly hypersensitivity, pregnancy-related and organ-function restrictions.
Warnings and Precautions
Important safety considerations include falls, fractures, rash and thyroid changes. The prescriber may require laboratory testing, cardiac or organ-function assessment, and ongoing monitoring.
Possible Side Effects
Potential adverse effects and serious reactions include falls, fractures, rash and thyroid changes. Other reactions can occur. Consult the product leaflet for the full adverse-effect profile and seek medical care for severe symptoms.
Drug Interactions
Drug interactions may affect treatment effectiveness or toxicity. Inform the treating clinician of all prescriptions, over-the-counter products, herbal supplements and other treatments.
Pregnancy, Fertility and Breastfeeding
Some oncology and hematology medicines can cause fetal harm and require specific contraception or breastfeeding restrictions. Follow the medicine-specific official labeling and specialist advice.
Storage and Handling
Store according to the instructions printed on the actual Beacon Pharmaceuticals pack. Protect from inappropriate heat, humidity and light, and keep out of reach of children. Do not assume the storage conditions of another brand apply.
Why Is Apaluda Listed as an Alternative to Erleada?
The comparison helps identify another listed brand containing Apalutamide. It does not establish identical formulation, regulatory approval, bioequivalence or permission to substitute.
Manufacturer Information
Listed brand: Apaluda. Manufacturer: Beacon Pharmaceuticals Ltd., Bangladesh. Reference brand: Erleada. Generic: Apalutamide. Strength: 60 mg. Dosage form: Tablet.
Frequently Asked Questions
What is Apaluda 60 mg? It is a tablet containing Apalutamide 60 mg according to the supplied Beacon price list. What is it used for? Apalutamide is used in selected advanced prostate cancer, subject to specialist assessment. Can it replace Erleada? Not automatically; a qualified professional must check product-specific equivalence and regulatory requirements. Is a prescription required? Yes, appropriate prescription and specialist supervision are necessary.
Important Medical Disclaimer
This listing is for educational pharmaceutical identification only and is not a substitute for medical advice, official product labeling or regulatory review. Brand, strength and pack details should be confirmed against the current manufacturer information before dispensing.
| Generic Name | Apalutamide |
|---|---|
| Strength | 60 mg |
| Manufacturer | Beacon Pharmaceuticals Ltd. |
Related products
Casodex 50 mg Alternative – Bical (Bicalutamide) 50 mg Tablet | Beacon Pharmaceuticals
Casodex 50 mg Alternative – Calupros (Bicalutamide) 50 mg Tablet | Everest Pharmaceuticals
Calupros 50 mg (Bicalutamide) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Casodex (AstraZeneca). It belongs to the nonsteroidal antiandrogen class and is used in selected prostate cancer hormonal treatment regimens.
Active ingredient: Bicalutamide
Strength: 50 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Erleada 60 mg Alternative – Prostaxen (Apalutamide) 60 mg Tablet | Everest Pharmaceuticals
Prostaxen 60 mg (Apalutamide) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Erleada (Janssen). It belongs to the androgen receptor inhibitor class and is used in selected castration-resistant or castration-sensitive prostate cancer settings.
Active ingredient: Apalutamide
Strength: 60 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Orgovyx 120 mg Alternative – Relugoli (Relugolix) 120 mg Tablet | Beacon Pharmaceuticals
Xtandi 40 mg Alternative – Zaluta (Enzalutamide) 40 mg Tablet | Beacon Pharmaceuticals
Zytiga 250 mg Alternative – Abiraxen (Abiraterone acetate) 250 mg Tablet | Everest Pharmaceuticals
Abiraxen 250 mg (Abiraterone acetate) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Zytiga (Janssen). It belongs to the androgen biosynthesis inhibitor class and is used in selected advanced prostate cancer regimens with corticosteroid therapy.
Active ingredient: Abiraterone acetate
Strength: 250 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Reviews
There are no reviews yet.